Research graph
References from Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
10.1001/jama.2023.24945 · 2024 · External reference
Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
10.1111/dom.14725 · 2022 · External reference
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial
10.1001/jama.2021.3224 · 2021 · External reference
Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity: a post hoc analysis of the SURMOUNT-4 trial
2025 · External reference
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
10.1136/heartjnl-2021-320171 · 2022 · External reference
Differential treatment effects on β-Cell function using model-based parameters in type 2 diabetes: results from the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE)
10.2337/dc24-2419 · 2025 · External reference
What is the clinical relevance of TNF inhibitor immunogenicity in the management of patients with rheumatoid arthritis?
10.3389/fimmu.2020.00589 · 2020 · External reference
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
10.1056/nejmoa066224 · 2006 · External reference
Potential therapeutic targets for Parkinson's disease
10.1517/14728222.12.4.425 · 2008 · External reference
Maintenance of lost weight and long-term management of obesity
2018 · External reference
Tirzepatide for obesity treatment and diabetes prevention
10.1056/nejmoa2410819 · 2024 · External reference
Waist to height ratio as a simple tool for predicting mortality: a systematic review and meta-analysis
10.1038/s41366-023-01388-0 · 2023 · External reference
Tirzepatide treatment and associated changes in β-Cell function and insulin sensitivity in people with obesity or overweight with prediabetes or normoglycemia: a post hoc analysis from the SURMOUNT-1 trial
10.2337/dc25-0763 · 2025 · External reference
A simple cut-off for waist-to-height ratio (0·5) can act as an indicator for cardiometabolic risk: recent data from adults in the Health Survey for England
10.1017/s0007114519003301 · 2020 · External reference
Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes
10.1001/jama.2018.14433 · 2018 · External reference
Tirzepatide associated with improved health-related quality of life in adults with obesity or overweight in SURMOUNT-4
10.1002/oby.70011 · 2025 · External reference
Effects of bariatric surgery on mortality in Swedish Obese Subjects
10.1056/nejmoa066254 · 2007 · External reference
Life expectancy after bariatric surgery in the Swedish Obese Subjects study
10.1056/nejmoa2002449 · 2020 · External reference
Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial
10.1136/heartjnl-2024-324170 · 2024 · External reference
